-+ 0.00%
-+ 0.00%
-+ 0.00%

Unicycive Therapeutics Q1 EPS $(0.54) Misses $(0.51) Estimate

Benzinga·05/12/2026 11:48:00
Listen to the news
Unicycive Therapeutics (NASDAQ:UNCY) reported quarterly losses of $(0.54) per share which missed the analyst consensus estimate of $(0.51) by 5.88 percent. This is a 8 percent decrease over losses of $(0.50) per share from the same period last year.